14358-33-9

14358-33-9 structure
14358-33-9 structure

Name h-dl-asp(ome)-ome hcl
Synonyms aspartic acid dimethyl ester hydrochloride
DL-ASPTIC ACID DIMETHYL ESTERHYDROCHLO RIDE CRYST
D-aspartic acid methyl ester hydrochloride
H-Asp(OMe)-OMe��HCl
1,4-dimethyl 2-aminobutanedioate hydrochloride
1,1-cyclopentane dicarboxylic acid dimethyl ester
cyclopentane-1,1-dicarboxylic acid dimethyl ester
DL-ASPTIC ACID A,B-DIMETHYLESTER HYDROCHLORIDE
dimethyl D-aspartate hydrochloride
DL-ASPTIC ACID(OME)-OME HCL
DL-ASPTIC ACID ALPHA,BETA-DIMETHYL ESTER HYDROCHLORIDE
DL-Asp(OMe)-OMe·HCl
Asciminib Impurity 16
dl-aspticaciddimethylesterHCl
Dimethyl aspartate hydrochloride (1:1)
H-DL-ASP(OME)-OME HCL //BP
dimethyl 2-aminosuccinate hydrochloride
D-aspartic acid dimethyl ester hydrochloride
(1,4-dimethoxy-1,4-dioxobutan-2-yl)azanium
DL-Asptic acid dimethyl ester hydrochloride (Assay: Anhydrous basis)
H-DL-ASP(OME)-OME HCL
Aspartic acid, dimethyl ester, hydrochloride (1:1)
Cyclopentan-1,1-dicarbonsaeure-dimethylester
DL-ASPTIC ACID DIMETHYL ESTER HYDROCHLORIDE
dimethyl 1,1-cyclopentanedicarboxylate
Description DL-Aspartic acid dimethyl ester hydrochloride is an aspartic acid derivative[1].
Related Catalog
In Vitro Amino acids and amino acid derivatives have been commercially used as ergogenic supplements. They influence the secretion of anabolic hormones, supply of fuel during exercise, mental performance during stress related tasks and prevent exercise induced muscle damage. They are recognized to be beneficial as ergogenic dietary substances[1].
References

[1]. Luckose F, et al. Effects of amino acid derivatives on physical, mental, and physiological activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

Boiling Point 223ºC at 760 mmHg
Melting Point 115-116.5℃ (ethanol ethyl acetate )
Molecular Formula C6H12ClNO4
Molecular Weight 197.617
Flash Point 88.9ºC
Exact Mass 197.045486
PSA 78.62000
LogP 0.55210
Vapour Pressure 0.0986mmHg at 25°C
Storage condition 2-8°C
Hazard Codes Xi
Risk Phrases 42/43
Safety Phrases 36/37

~99%

14358-33-9 structure

14358-33-9

Literature: Weber, Frauke; Brune, Stefanie; Korpis, Katharina; Bednarski, Patrick J.; Laurini, Erik; Dal Col, Valentina; Pricl, Sabrina; Schepmann, Dirk; Wuensch, Bernhard Journal of Medicinal Chemistry, 2014 , vol. 57, # 7 p. 2884 - 2894

~99%

14358-33-9 structure

14358-33-9

Literature: Colombo, Raffaele; Mingozzi, Michele; Belvisi, Laura; Arosio, Daniela; Piarulli, Umberto; Carenini, Nives; Perego, Paola; Zaffaroni, Nadia; De Cesare, Michelandrea; Castiglioni, Vittoria; Scanziani, Eugenio; Gennari, Cesare Journal of Medicinal Chemistry, 2012 , vol. 55, # 23 p. 10460 - 10474

~%

14358-33-9 structure

14358-33-9

Literature: Feenstra, R. W.; Stokkingreef, E. H. M.; Nivard, R. J. F.; Ottenheijm, H. C. J. Tetrahedron Letters, 1987 , vol. 28, # 11 p. 1215 - 1218
Precursor  4

DownStream  0

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.